Idorsia Ltd.
ISIN CH0363463438
|WKN A2DTEB
Overview
Description
Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, and Rest of World. The was founded on March 3, 2017 and is headquartered in Allschwil, Switzerland.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 431.45 m |
| EPS, EUR | -0.61 |
| P/B ratio | - |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 156.95 m |
| Net income, EUR | -306.84 m |
| Profit margin | -195.50% |
What ETF is Idorsia Ltd. in?
There are 11 ETFs which contain Idorsia Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Idorsia Ltd. is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| iShares Core SPI (CH) | 0.02% | Equity Switzerland | 205 | 0.10% | 3,465 | +11.09% | A110UZ | CH0237935652 |
| iShares Ageing Population UCITS ETF | 0.04% | Equity World Health Care Social/Environmental Ageing Population | 337 | 0.40% | 431 | +12.62% | A2ANH1 | IE00BYZK4669 |
| Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing | 0.00% | Equity Europe Social/Environmental | 1,046 | 0.12% | 20 | +17.81% | A3DJQ9 | IE000NRGX9M3 |
| UBS ETF (CH) SPI Mid (CHF) A-dis | 0.11% | Equity Switzerland Mid Cap | 80 | 0.25% | 454 | +6.35% | A1JB24 | CH0130595124 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,810 | 0.24% | 292 | +25.26% | A2QL8V | IE00BNG8L385 |
| UBS ETF (CH) SPI® ESG (CHF) A-acc | 0.02% | Equity Switzerland Social/Environmental | 165 | 0.15% | 1,241 | +11.19% | A2QN8C | CH0590186661 |
| UBS ETF (CH) SPI (CHF) A-dis | 0.02% | Equity Switzerland | 194 | 0.10% | 1,397 | +11.53% | A1JB69 | CH0131872431 |
| Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Accumulating | 0.00% | Equity Europe Social/Environmental | 1,046 | 0.12% | 79 | +17.90% | A3DJTF | IE000QUOSE01 |
| iShares Healthcare Innovation UCITS ETF | 0.05% | Equity World Health Care Social/Environmental Innovation | 195 | 0.40% | 1,022 | +4.73% | A2ANH2 | IE00BYZK4776 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,810 | 0.24% | 375 | +25.27% | A2QL8U | IE00BNG8L278 |
| L&G Pharma Breakthrough UCITS ETF | 3.04% | Equity World Health Care Innovation | 43 | 0.49% | 17 | -1.66% | A2H9XR | IE00BF0H7608 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.